FDA Panel Endorses COVID Boosters – But Not for Everyone
The Food and Drug Administration (FDA) voted 16-2 to reject a proposal to administer widespread Pfizer COVID-19 vaccine booster shots. Instead, they unanimously endorsed the third dose shot only for those over age 65 or who are at increased risk of severe disease.
“I don’t think a booster dose is going to significantly contribute to controlling the pandemic,” said Dr. Cody Meissner of Tufts University, a member of the advisory panel. “And I think it’s important that the main message we transmit is that we’ve got to get everyone two doses.”
The Centers for Disease Control and Prevention (CDC) Advisory Committee will meet in the coming days to determine if they approve booster doses for the Pfizer COVID-19 vaccine. They have noted that it is considering boosters for the elderly, nursing home residents, and frontline healthcare workers, as opposed to a widespread recommendation.
Dr. Amanda Cohn of the CDC said, “At this moment it is clear that the unvaccinated are driving transmission in the United States.”
Baptist Health is continuing to provide first dose COVID-19 vaccines, and is now offering third doses for those with compromised immune systems. When health regulators approve boosters for the general public, Baptist Health will be ready to provide them according to recommendations.
Next Steps and Useful Resources: